BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Equibles//Investor Events//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
NAME:Lantern Pharma Inc. (LTRN) investor events
X-WR-CALNAME:Lantern Pharma Inc. (LTRN) investor events
DESCRIPTION:Earnings calls and investor events for Lantern Pharma Inc. (LTR
 N)\, from Equibles.
X-WR-CALDESC:Earnings calls and investor events for Lantern Pharma Inc. (LT
 RN)\, from Equibles.
REFRESH-INTERVAL;VALUE=DURATION:PT6H
X-PUBLISHED-TTL:PT6H
BEGIN:VEVENT
UID:8dc65836-7441-41a0-9dbd-1351d30d4901@equibles.com
DTSTAMP:20260610T190052Z
DTSTART:20251113T140000Z
DTEND:20251113T150000Z
SEQUENCE:0
STATUS:CONFIRMED
TRANSP:TRANSPARENT
SUMMARY:Lantern Pharma Inc. (LTRN) Earnings Call\, FY2025 Q3
DESCRIPTION:Webcast: https://youtu.be/o3S2QiUDMrQ
URL:https://equibles.com/stocks/ltrn/calls/2025-q3
END:VEVENT
BEGIN:VEVENT
UID:221ae6ec-c4ca-4587-8246-31af57df58cf@equibles.com
DTSTAMP:20260909T015845Z
DTSTART:20260304T230000Z
DTEND:20260305T000000Z
SEQUENCE:0
STATUS:CONFIRMED
TRANSP:TRANSPARENT
SUMMARY:Lantern Pharma Inc. (LTRN) Investor Update: New to the Street Inves
 tor Event
DESCRIPTION:New to the Street Investor Event\nWebcast: https://ir.lanternph
 arma.com/events-and-presentations/event-details/2026/New-to-the-Street-Inv
 estor-Event-2026-BkbM4BHuHG/default.aspx
END:VEVENT
BEGIN:VEVENT
UID:358f8c4d-8ce3-4649-9aa2-b1589c8a444c@equibles.com
DTSTAMP:20260617T191113Z
DTSTART;VALUE=DATE:20260330
DTEND;VALUE=DATE:20260331
SEQUENCE:0
STATUS:CONFIRMED
TRANSP:TRANSPARENT
SUMMARY:Lantern Pharma Inc. (LTRN) Earnings Call\, FY2025 Q4
DESCRIPTION:The start time has not been announced.\nWebcast: https://ir.lan
 ternpharma.com/events-and-presentations/event-details/2026/Q4-and-Fiscal-Y
 ear-2025-Operating--Financial-Results-Webcast-2026-CC5Yi5q3At/default.aspx
URL:https://equibles.com/stocks/ltrn/calls/2025-q4
END:VEVENT
BEGIN:VEVENT
UID:df6d3c10-7a6f-400f-a662-120dcb5c7c18@equibles.com
DTSTAMP:20260617T190809Z
DTSTART;VALUE=DATE:20260515
DTEND;VALUE=DATE:20260516
SEQUENCE:0
STATUS:CANCELLED
TRANSP:TRANSPARENT
SUMMARY:Lantern Pharma Inc. (LTRN) Earnings Call\, FY2026 Q1
DESCRIPTION:No call was held: the company published its results without one
 .
END:VEVENT
BEGIN:VEVENT
UID:3d6a25b4-da32-495c-80da-603fb54397ee@equibles.com
DTSTAMP:20260813T052846Z
DTSTART;VALUE=DATE:20260814
DTEND;VALUE=DATE:20260815
SEQUENCE:0
STATUS:CONFIRMED
TRANSP:TRANSPARENT
SUMMARY:Lantern Pharma Inc. (LTRN) Earnings Call\, FY2026 Q2
DESCRIPTION:The start time has not been announced.\nWebcast: https://us06we
 b.zoom.us/webinar/register/7017858906483/WN_muTjUTZiTNC4JYT9RXcKfQ#/regist
 ration
URL:https://equibles.com/stocks/ltrn/calls/2026-q2
END:VEVENT
BEGIN:VEVENT
UID:5c0b3694-b415-4f7c-9f87-f756f173f296@equibles.com
DTSTAMP:20261008T222145Z
DTSTART:20261015T193000Z
DTEND:20261015T203000Z
SEQUENCE:0
STATUS:CONFIRMED
TRANSP:TRANSPARENT
SUMMARY:Lantern Pharma Inc. (LTRN) Conference: ThinkEquity Conference
DESCRIPTION:ThinkEquity Conference\nWebcast: https://event.summitcast.com/v
 iew/GXv6JAoMEphytK6ggozCk7/VS4pGMrvkgq2xwHrNQevWX
URL:https://equibles.com/stocks/ltrn/events/5c0b3694-b415-4f7c-9f87-f756f17
 3f296
END:VEVENT
END:VCALENDAR